KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Global Medical REIT (GMRE) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Global Medical REIT (GMRE) over the last 14 years, with Q3 2025 value amounting to $13.4 million.

  • Global Medical REIT's Shares Outstanding (Weighted Average) rose 187.11% to $13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.4 million, marking a year-over-year increase of 187.11%. This contributed to the annual value of $65.9 million for FY2024, which is 58.89% up from last year.
  • As of Q3 2025, Global Medical REIT's Shares Outstanding (Weighted Average) stood at $13.4 million, which was up 187.11% from $66.9 million recorded in Q2 2025.
  • Global Medical REIT's Shares Outstanding (Weighted Average)'s 5-year high stood at $66.9 million during Q2 2025, with a 5-year trough of $13.1 million in Q3 2024.
  • For the 5-year period, Global Medical REIT's Shares Outstanding (Weighted Average) averaged around $59.0 million, with its median value being $65.5 million (2022).
  • In the last 5 years, Global Medical REIT's Shares Outstanding (Weighted Average) soared by 3687.22% in 2021 and then tumbled by 7994.81% in 2024.
  • Quarter analysis of 5 years shows Global Medical REIT's Shares Outstanding (Weighted Average) stood at $60.6 million in 2021, then grew by 7.95% to $65.5 million in 2022, then rose by 0.13% to $65.6 million in 2023, then increased by 0.59% to $65.9 million in 2024, then crashed by 79.69% to $13.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $13.4 million in Q3 2025, compared to $66.9 million in Q2 2025 and $66.9 million in Q1 2025.